Evidence map›Paper›PMID 40963636›Full record

ArticleFrontiers in immunology2025

Co-expression of PD1+ and HLA-DR+ in CD8+ T cells is increased in tonsils of children with EBV primary and persistent infection.

María Eugenia Amarillo, Karen Lindl, Veronica Lapido, Ignacio E Rojas Campión, M Soledad Collado, Johanna Speratti, Andrea Valerio, Plácida Baz, Elena De Matteo, L Ariel Billordo and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Splenic PD-L1Research (Washington, D.C.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

María Eugenia AmarilloMultidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), National Council for Scientific and Technological Research (CONICET)-GCBA, Laboratory of Molecular Biology, Pathology Division, Ricardo Gutiérrez Children's Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
Karen LindlMultidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), National Council for Scientific and Technological Research (CONICET)-GCBA, Laboratory of Molecular Biology, Pathology Division, Ricardo Gutiérrez Children's Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
Veronica LapidoMultidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), National Council for Scientific and Technological Research (CONICET)-GCBA, Laboratory of Molecular Biology, Pathology Division, Ricardo Gutiérrez Children's Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
Ignacio E Rojas CampiónMultidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), National Council for Scientific and Technological Research (CONICET)-GCBA, Laboratory of Molecular Biology, Pathology Division, Ricardo Gutiérrez Children's Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
M Soledad ColladoInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Johanna SperattiOtorhinolaryngology Division, Ricardo Gutierrez Children Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
Andrea ValerioOtorhinolaryngology Division, Ricardo Gutierrez Children Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
Plácida BazInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Elena De MatteoPathology Division, Ricardo Gutierrez Children Hospital, Ciudad Autónoma de Buenos Aires, Argentina.
L Ariel BillordoInstitute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Paola ChabayMultidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), National Council for Scientific and Technological Research (CONICET)-GCBA, Laboratory of Molecular Biology, Pathology Division, Ricardo Gutiérrez Children's Hospital, Ciudad Autónoma de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Epstein-Barr virus (EBV) infects B lymphocytes and establishes lifelong persistence in the B cells. While systemic T-cell responses have been well characterized, the local immune response at the site of viral entry in children from undeveloped countries remains poorly understood. Methods: Tonsillar CD4 and CD8 T cells in 32 pediatric patients undergoing tonsillectomy were classified as primary infected (PI), EBV carriers (EC), and non-infected children by serology. T-cell subsets were assessed by flow cytometry, whereas LMP1 and EBNA2 viral proteins were evaluated by immunohistochemistry. Results: A higher percentage of activated HLA-DR+ CD8 T cells in PI patients was demonstrated. Notably, PD-1 expression was increased in both PI and EC, in particular in activated HLA-DR+ CD8 T cells. Positive correlations of EBNA2 with follicular helper T cells and Th1 cells, as well as a negative correlation between EBNA2 and activated CD8 T cells, were observed. Discussion: These findings suggest that, during asymptomatic primary infection by EBV, activated CD8 T cells are observed, but they may be cells that may exhibit features of exhaustion, which probably explains the absence of symptoms. PD-1 expression in CD8 T cells remains in EC. Additionally, Tfh, Th1, and CD8 T cells may influence the expression of EBNA2 and LMP1 latent viral antigens in tonsils.

Indexed as

CD8-Positive T-LymphocytesEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHLA-DR AntigensPalatine TonsilProgrammed Cell Death 1 ReceptorAdolescentChildChild, PreschoolFemaleHumansInfantMaleHLA-DR AntigensPDCD1 protein, humanProgrammed Cell Death 1 ReceptorCD4+ T cellCD8+ T cellschildrenEBVtonsil

Identifiers

PMID40963636
PMCPMC12436462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.